Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ASSURE: An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)

NCT03301506 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT03301506
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03301506 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ASSURE: An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)
Lead sponsor
Gilead Sciences
Phase
Phase 3
Overall status
Active, not recruiting
Start date
December 12, 2017
Completion date
December 31, 2028
Enrollment
340 (estimated)
Sites
109

Conditions

As the registry lists them; a condition with its own page is linked.

primary biliary cirrhosis